This enduring education aims to enhance clinicians knowledge and competence in optimizing subcutaneous anti-CD38 therapies for MM to improve patient access, clinic workflows, and treatment adherence. As a result of this educational curriculum, learners will be better able to: 1. Recognize the rationale for using SC formulations of anti-CD38 monoclonal antibodies in patients with MM; 2. Assess clinical profiles of approved and emerging SC formulations of anti-CD38 monoclonal antibodies in patients with MM; and, 3. Outline evidence-based, patient-centered strategies for optimizing outcomes with SC formulations of anti-CD38 monoclonal antibodies in patients with MM. Learners have access to downloadable materials for future use in practice.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
99% of listed courses are free
156 of 157 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General Internal Medicine
- General Pediatrics
- General Surgery
- Gynecologic Oncology
- Hematology
- Infectious Disease
- Interventional Cardiology
- Maternal-Fetal Medicine
- Medical Oncology
- Nephrology
- Neurocritical Care
- Neurology
- Neuromuscular Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pediatric Gastroenterology
- Pediatric Infectious Diseases
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Transplant Hepatology
- Urological Oncology
- Urology
- Vascular Neurology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pathology & Lab
- Pediatrics
- Primary care
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Microlearning
- includes Online course / module
- Credit · Up to 0.5 credits
- Commercial Support
-
ReleasedJun 22, 2026
-
Last day to claim creditJun 22, 2027 8 months left
-
Global Learning Collaborative The Frontline Imperative: Integrating Anti-CD38 Based Regimens Into Multiple Myeloma Care in Community Practice
-
Medscape, LLC Case-Based Guide for CD38-Targeted Monoclonal Antibody Therapy in the Treatment of Multiple Myeloma
-
PRIME Education, Inc. (PRIME®) Maximizing Outcomes in Transplant-Eligible Multiple Myeloma: Evidence-Based Quadruplet Selection and Management
-
Answers in CME Inc. (AiCME) Optimizing Frontline Care in NDMM: Translating Recent Advances Into Practice
-
Answers in CME Inc. (AiCME) From Evidence to Practice: Where Do BCMA Bispecific Antibodies and Anti-CD38 mAb Combinations Fit Into Community Care for RRMM?
-
Answers in CME Inc. (AiCME) Mastering Anti-CD38 Therapy in Multiple Myeloma Care: Case-Based Education for Oncology Nurses and Advanced Practitioners
